SOLICITATION NOTICE
66 -- Piccolo Express Chemistry Analyzer
- Notice Date
- 2/8/2016
- Notice Type
- Presolicitation
- NAICS
- 423850
— Service Establishment Equipment and Supplies Merchant Wholesalers
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2016-Q-64709
- Point of Contact
- Shelley E. Kreimer, Phone: 7704882048
- E-Mail Address
-
xky4@cdc.gov
(xky4@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- THIS NOTICE IS FOR INFORMATIONAL PURPOSES ONLY. The Centers for Disease Control and Prevention (CDC), Center for Global Health, Division of Parasitic Diseases and Malaria contemplates the award of a firm-fixed-price sole source purchase order to Fisher Healthcare at 9999 Veterans Memorial Drive, Houston TX 77038-2401 for providing Piccolo Xpress, a fully automated advanced diagnostic instrument that provides routine testing of blood samples in only twelve minutes, requiring only 100ul of sample. Abbott Point of Care is the exclusive US distributor of Piccolo Xpress, a fully automated advanced diagnostic instrument that provides routine testing of blood samples in 12 minutes, and requiring only 100ul of sample. Fisher Healthcare is the preferred distributor of Abbot Point of Care products and the HHS strategic source for laboratory equipment, reagents, and supplies. Abbot Point of Care does not sell the instrument directly, however they provide warranty, maintenance and consumable support to Fisher Healthcare to ensure continued instrument performance. The Piccolo Xpress point of care biochemistry analyser is a compact, portable, fully automated clinical chemistry system designed for on-site patient testing, which is vital for use in field conditions, where it will be used. The Piccolo analyzer is the only instrument able to perform routine multi-chemistry panels, using only 100ul of whole blood, serum or plasma, using patented 8-cm diameter single use plastic discs containing the liquid diluent and dry reagents. The Piccolo Xpress monitors the reagent reactions simultaneously using nine wavelengths, calculates the results from the absorbance data and reports the results. The Piccolo Xpress blood chemistry analyser self-calibrates with each run and the on-board continuous intelligent Quality Control (iQC™) monitors the analyser, reagent reactions and sample to ensure chemistry and instrument integrity. Results are delivered in approximately 12 minutes, enabling rapid diagnostic information at point of collection. The easy-to-use, maintenance-free system requires no special training to operate, making it uniquely suited for use in low-resource field settings. This acquisition will use sole source simplified procedures in accordance with FAR 13.106(b)(1). This requirement is not set aside for small businesses. CDC is not requesting competitive proposals and no solicitation is available. Interested parties who believe they possess the capabilities to satisfy this requirement should indicate their interest in writing and submit a capability statement demonstrating their ability to meet this requirement no later than 10:30 AM Eastern Standard Time, on February 11, 2016. Determination not to compete this proposed action based on responses to this notice is solely within the discretion of the Government. Respondents will assume all financial costs for preparing a response to this notice. The U.S. Government assumes no financial obligation for the preparation and distribution of prepared responses. Inquiries may be sent to Shelley E. Kreimer, Esq. via email at xky4@cdc.gov
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2016-Q-64709/listing.html)
- Record
- SN04013860-W 20160210/160208235008-7f3a2b4642c0879e6203cca42cd5ece3 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |